Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.] · 2025
Water avoidance stress exacerbates orthotopic pancreatic cancer growth by suppressing cytotoxic T lymphocyte infiltration.
СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Nishii Shin, Okada Yoshikiyo, Mizoguchi Akinori, Sugihara Nao, Nishimura Hiroyuki, Ayaki Kana, Yoshidome Yuta, Tahara Hiroyuki, Horiuchi Tomoaki, Takahashi Shun, Hirata Dai, Kurihara Chie, Narimatsu Kazuyuki, Komoto Shunsuke, Tomita Kengo, Asai Fumiho, Koga Minori, Morimoto Yuji, Imaeda Hiroyuki, Tsuzuki Yoshikazu, Hokari Ryota
Аннотация
BACKGROUND/OBJECTIVES: The incidence of pancreatic cancer is increasing, and it has a poor prognosis. Also, it is often refractory to standard chemotherapy. Psychological stress influences the development of some malignant neoplasms; however, its immunological mechanism is unclear. In this study, we investigated whether water avoidance stress (WAS) promotes mouse orthotopic pancreatic cancer growth and the mechanism through which WAS influences anticancer immunological responses.
METHODS: Mouse pancreatic adenocarcinoma cells were orthotopically inoculated into the pancreas of mice. After 2 weeks, the mice were assigned to receive either WAS or sham. After 6 weeks of tumor inoculation, the tumor volume was calculated. The peritumoral interferon-gamma (IFN-γ) and tumor necrosis factor-alpha (TNF-α) were measured; lymphocytes in the pancreas were isolated and analyzed. CD4+ and CD8+ T lymphocyte peritumoral infiltration and intercellular adhesion molecule 1 (ICAM-1) expression were analyzed. Tumor-bearing mice were subjected to either WAS or control; the number of adhesive lymphocytes was calculated.
RESULTS: WAS promoted pancreatic cancer growth, and suppressed peritumoral IFN-γ mRNA expression, and cytotoxic T lymphocyte peritumoral infiltration. WAS also suppressed peritumoral lymphocyte adhesion, ICAM-1 expression in the vascular endothelium in the peritumoral region, and peritumoral TNF-α mRNA expression.
CONCLUSION: Our results suggest that in the peritumoral region, WAS suppressed anticancer immunological responses by the suppression of TNF-α secretion, ICAM-1 expression, lymphocyte adhesion, cytotoxic T lymphocyte infiltration, and IFN-γ secretion, thereby promoted pancreatic cancer growth. Inducing the upregulation of adhesion molecules and augmentation of cytotoxic T cell recruitment may lead to the development of new treatments for pancreatic cancer.
METHODS: Mouse pancreatic adenocarcinoma cells were orthotopically inoculated into the pancreas of mice. After 2 weeks, the mice were assigned to receive either WAS or sham. After 6 weeks of tumor inoculation, the tumor volume was calculated. The peritumoral interferon-gamma (IFN-γ) and tumor necrosis factor-alpha (TNF-α) were measured; lymphocytes in the pancreas were isolated and analyzed. CD4+ and CD8+ T lymphocyte peritumoral infiltration and intercellular adhesion molecule 1 (ICAM-1) expression were analyzed. Tumor-bearing mice were subjected to either WAS or control; the number of adhesive lymphocytes was calculated.
RESULTS: WAS promoted pancreatic cancer growth, and suppressed peritumoral IFN-γ mRNA expression, and cytotoxic T lymphocyte peritumoral infiltration. WAS also suppressed peritumoral lymphocyte adhesion, ICAM-1 expression in the vascular endothelium in the peritumoral region, and peritumoral TNF-α mRNA expression.
CONCLUSION: Our results suggest that in the peritumoral region, WAS suppressed anticancer immunological responses by the suppression of TNF-α secretion, ICAM-1 expression, lymphocyte adhesion, cytotoxic T lymphocyte infiltration, and IFN-γ secretion, thereby promoted pancreatic cancer growth. Inducing the upregulation of adhesion molecules and augmentation of cytotoxic T cell recruitment may lead to the development of new treatments for pancreatic cancer.